Biogen Idex (BIIB) CEO Scangos Says New MS Treatment Will Bolster Offerings

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/15/2026

1. AMAT
2. GLOB
3. SPY
4. RDDT
5. HTFL
6. SNDK
7. WDAY
8. ADYEN:NA
9. ADYYF
10. DVLT

Go back to Biogen Idex (BIIB) CEO Scangos Says New MS Treatment Will Bolster Offerings
BIOGEN IDEC Inc. (NASDAQ: BIIB) Delayed: 209.83 -0.82 (0.39%)
Previous Close $210.65    52 Week High $333.65 
Open $210.01    52 Week Low $223.02 
Day High $210.79    P/E 26.87 
Day Low $208.22    EPS $7.81 
Volume 554,817